GGrantIndex
Sort

34,240 grants matching atherosclerosis

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$720,165
Sanjay Srivastava · University Of Louisville · R01 · FY2023 · HL

Translational Studies of Age-Associated Arterial Dysfunction, Western Diet and Aerobic Exercise: Role of the Gut Microbiome

$719,929
Douglas R Seals · University Of Colorado · R01 · FY2020 · HL

Sleep Apnea in TIA: Reducing Cardiovascular Risk with Positive Airway Pressure

$719,917
Henry Klar Yaggi · Yale University · U34 · FY2010 · HL

CHARGE consortium: gene discovery for CVD and aging phenotypes

$719,875
Bruce M Psaty · University Of Washington · R01 · FY2015 · HL

Modulation of chemokine signaling to mitigate radiation induced inflammation

$719,784
Subhrajit Saha · University Of Kansas Medical Center · U01 · FY2022 · AI

Activation trajectories of integrin α5β1

$719,617
Timothy A Springer · Boston Children'S Hospital · R01 · FY2024 · HL

Subclinical Interstitial Lung Disease in MESA

$719,463
David J. Lederer · Columbia University Health Sciences · R01 · FY2013 · HL

Obesity, Inflammation and Thrombosis: LOOK AHEAD

$719,422
Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2008 · HL

Validation of a Rodent Mutagenicity Assay

$719,092
Stephen D Dertinger · Litron Laboratories, Ltd. · R44 · FY2011 · ES

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

$719,085
Sanjay Srivastava · University Of Louisville · R01 · FY2022 · HL

EphA2 regulation of atherosclerotic smooth muscle phenotype

$719,050
Anthony Wayne Orr · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · HL

EphA2 regulation of atherosclerotic smooth muscle phenotype

$719,050
Anthony Wayne Orr · Louisiana State Univ Hsc Shreveport · R01 · FY2024 · HL

Genetics Myocardial Adverse Outcomes/Graft Failure-CABG

$719,029
Debra A. Schwinn · Duke University · R01 · FY2006 · HL

Multiethnic machine learning brain signatures of ADRD

$718,849
Mohamad Habes · University Of Texas Hlth Science Center · R01 · FY2024 · AG

Diabetes Prevention Program Outcomes Study - Phase 2

$718,669
Vanita Aroda · Medstar Health Research Institute · U01 · FY2013 · DK

Copper transport protein and inflammatory angiogenesis

$718,635
Tohru Fukai · University Of Illinois At Chicago · R01 · FY2015 · HL

Comprehensive CT Guided Coronary Artery Bypass Graft Surgery

$718,630
Koen Nieman · Stanford University · R01 · FY2021 · HL

Cellular and Circulating Fortilin in Vascular Diseases

$718,619
Ken Fujise · University Of Washington · R01 · FY2020 · HL

CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CHRONIC KIDNEY DISEASE PATIENTS

$718,609
Tanika Nicole Kelly · Tulane University Of Louisiana · R01 · FY2021 · DK

Individualized Risk Stratification Using the Genomic Contribution

$718,570
Gary Wayne Beecham · University Of Miami School Of Medicine · R01 · FY2014 · HL

Promoting Walking in African Americans with Peripheral Arterial Disease

$718,411
Tracie Chianti Collins · University Of Kansas Medical Center · R01 · FY2011 · HL

Primary Prevention to Reduce Cardiovascular Morbidity and Optimize Cancer Outcomes

$718,362
Aniket A Kawatkar · Kaiser Foundation Research Institute · R01 · FY2022 · HL

Basic Cardiovascular Research Training Grant

$718,361
Gary K Owens · University Of Virginia · T32 · FY2014 · HL

An Interpersonal Relationships Intervention for Improving Cardiovascular Health in Youth

$718,224
Edith Chen · Northwestern University · R01 · FY2022 · HL

Randomized trial of vitamin D and omega-3 fatty acids for diabetic kidney disease

$718,107
Ian H De Boer · University Of Washington · R01 · FY2017 · DK